Model Answer
0 min readIntroduction
Cytotoxic T lymphocytes (CTLs), often referred to as killer T cells or CD8+ T cells, are crucial components of the adaptive immune system, primarily responsible for identifying and eliminating cells infected with intracellular pathogens, such as viruses and bacteria, as well as cancerous cells [1, 14]. Unlike antibodies that target extracellular pathogens, CTLs directly engage and destroy compromised host cells, preventing the spread of infection or tumor growth [11]. Their mechanism of action is highly specific and tightly regulated to ensure the elimination of harmful cells while sparing healthy tissues, playing an indispensable role in maintaining immune homeostasis and protecting against various diseases [4, 16].
Activation of Cytotoxic T Cells
The activation of naive CD8+ T cells is a multi-step process that typically occurs in secondary lymphoid organs, such as lymph nodes. It requires two main signals from antigen-presenting cells (APCs), primarily dendritic cells [3, 4, 18]:- Signal 1: T-cell Receptor (TCR) Recognition: The T-cell receptor (TCR) on the surface of the CD8+ T cell recognizes specific foreign peptides (antigens) presented by Major Histocompatibility Complex class I (MHC-I) molecules on the APC. MHC-I molecules are found on almost all nucleated cells in the body, making them ideal for displaying intracellular threats [13, 14]. The CD8 co-receptor on the CTL binds to a non-polymorphic region of the MHC-I molecule, stabilizing the interaction [13].
- Signal 2: Co-stimulation: For full activation, the T cell requires co-stimulatory signals. The most well-known involves the binding of CD28 on the T cell to B7 molecules (CD80/CD86) on the APC. This signal ensures that the T cell only mounts a robust response when a genuine threat is present, preventing autoimmune reactions [4, 18].
- Signal 3: Cytokine Signaling (Differentiation): Cytokines secreted by APCs, especially interleukin-2 (IL-2) produced by activated helper T cells, drive the proliferation and differentiation of activated CD8+ T cells into effector CTLs and memory T cells [10, 12, 18].
Mechanisms of Action of Cytotoxic T Cells
Activated CTLs employ two primary mechanisms to induce apoptosis (programmed cell death) in target cells: the perforin-granzyme pathway and the Fas-FasL pathway.1. Perforin-Granzyme Pathway (Granule Exocytosis Pathway)
This is the predominant and fast-acting mechanism used by CTLs [2, 16, 21]. Upon encountering a target cell presenting the specific antigen on its MHC-I molecule, the CTL forms an "immunological synapse" with the target cell. Within this synapse, the CTL rapidly repositions its lytic granules towards the target cell membrane [9, 16].- Perforin Release: The CTL releases perforin, a pore-forming protein, from its lytic granules [4, 16]. Perforin polymerizes in the target cell membrane, creating pores or channels [5, 16].
- Granzyme Entry: Through these perforin-formed pores, granzymes (serine proteases, e.g., Granzyme A and Granzyme B) enter the cytoplasm of the target cell [4, 5, 23].
- Apoptosis Induction:
- Granzyme B: Primarily activates a cascade of caspases (cysteine-aspartic proteases), such as caspase-3, which dismantle cellular structures and DNA, leading to apoptosis [2, 4, 25]. It can also directly activate pro-apoptotic members of the BCL-2 family [2].
- Granzyme A: Targets cellular DNA replication mechanisms, leading to single-stranded DNA nicks and eventually cell dysfunction [6]. It can also induce mitochondrial dysfunction [6].
- CTL Detachment: After inducing apoptosis, the CTL detaches from the dying target cell and can move on to destroy other infected or abnormal cells, acting as a serial killer [16].
2. Fas-Fas Ligand (Fas-FasL) Pathway
This pathway is a slower-acting but equally crucial mechanism, particularly important for eliminating self-reactive lymphocytes and for long-term immune regulation [8, 15, 21].- FasL Expression: Activated CTLs express Fas ligand (FasL) on their cell surface [15, 20].
- Fas Receptor Engagement: Many target cells, especially those undergoing stress or viral infection, express the Fas receptor (CD95/APO-1) on their surface [15]. When FasL on the CTL binds to Fas on the target cell, it triggers a signaling cascade within the target cell [15, 20].
- Death-Inducing Signaling Complex (DISC) Formation: The binding of FasL to Fas leads to the recruitment of adapter proteins and pro-caspase-8, forming the Death-Inducing Signaling Complex (DISC) [21].
- Caspase Activation and Apoptosis: Pro-caspase-8 is activated within the DISC, leading to the activation of downstream effector caspases (like caspase-3), which execute apoptosis [15, 21, 25].
Both pathways ultimately lead to the controlled dismantling of the target cell, preventing inflammation and damage to surrounding healthy tissues, distinguishing it from necrosis [23].
Role of Cytokines
CTLs also release cytokines such as Interferon-gamma (IFN-γ) and Tumor Necrosis Factor-alpha (TNF-α). These cytokines:- Enhance the immune response by activating macrophages and other immune cells [4, 7, 24].
- Have antiviral and anti-tumor effects, inhibiting viral replication and tumor cell growth [7, 14].
The table below summarizes the key differences between the two primary killing mechanisms of CTLs:
| Feature | Perforin-Granzyme Pathway | Fas-FasL Pathway |
|---|---|---|
| Mechanism | Granule exocytosis of perforin and granzymes | Receptor-ligand interaction (FasL on CTL, Fas on target) |
| Speed of Action | Fast-acting, immediate cell death | Slower-acting, delayed cell death |
| Key Molecules | Perforin, Granzymes (A, B) | Fas Ligand (FasL), Fas receptor |
| Primary Role | Elimination of virus-infected and tumor cells | Apoptosis of self-reactive lymphocytes, immune regulation, some pathogen/tumor elimination |
| Caspase Activation | Indirect (Granzyme B activates caspases) | Direct (DISC formation activates Caspase-8) |
Conclusion
Cytotoxic T cells are indispensable components of the adaptive immune system, serving as cellular assassins that precisely target and eliminate host cells compromised by intracellular pathogens or cancerous transformations. Their highly regulated activation, involving MHC-I presentation and co-stimulation, ensures specificity. The subsequent execution mechanisms, primarily through the perforin-granzyme pathway and the Fas-FasL pathway, orchestrate programmed cell death, effectively preventing disease progression while minimizing collateral damage to healthy tissues. Understanding these intricate mechanisms is crucial not only for appreciating the robustness of our immune defense but also for developing advanced immunotherapies against infections, autoimmune disorders, and cancer.
Answer Length
This is a comprehensive model answer for learning purposes and may exceed the word limit. In the exam, always adhere to the prescribed word count.